Lunaphore launches Comet antibody instrument in U.K.

By The Science Advisory Board staff writers

May 9, 2022 -- Lunaphore installed its Comet Primary Antibodies (PA) instrument at Propath U.K., the first contract research organization (CRO) in Europe to offer the service.

Comet PA is an automated sequential immunofluorescence (seqIF) instrument that performs hyperplex staining and imaging. It allows multiplex analysis of up to 40 different spatial markers per tissue slide without human intervention, according to Lunaphore.

The instrument can aid understanding in the areas of immuno-oncology, neuroscience, and infectious diseases, the firm added.


Copyright © 2022 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.